1 Tankeu A T,Bigna J J,Nansseu J R,et al. Global prevalence of diabetes mellitus in patients with tuberculosis: a systematic review and meta-analysis protocol[J]. BMJ Open,2017,7(6):e015170.
2 Zhang L,Shi X,Zhang Y,et al. Analysis of Factors Inuencing Diagnostic Accuracy of T-SPOT.TB for Active Tuberculosis in Clinical Practice[J]. Sci Rep,2017,7(1):7764-7768.
3 中华人民共和国卫生部. WS288-2008肺结核诊断标准[M]. 北京:人民卫生出版社,2008:1-16.
4 Ji L,Lou Y,Wu Z,et al. Usefulness of interferon-γ release assay for the diagnosis of sputum smear-negative pulmonary and extra-pulmonary TB in Zhejiang Province,China[J]. Infect Dis Poverty,2017,6(1):121-125.
5 Kim C H,Kim J Y,Hwang Y I,et al. Interferon-γ Enzyme-Linked Immunospot Assay in Patients with Tuberculosis and Healthy Adults[J]. Tuberc Respir Dis (Seoul),2014,76(1):23-29.
6 Kobashi Y,Obase Y,Fukuda M,et al. Clinical reevaluation of the QuantiFERON TB-2G test as a diagnostic method for differentiating active tuberculosis from nontuberculous mycobacteriosis[J]. Clin Infect Dis,2006,43(12):1540-1546.
7 YangF,Tu Z,Fang Y,et al. Monitoring of peptide-specific and gamma interferon-productive T cells in patients with active and convalescent tuberculosis using an enzyme-linked immunosorbent spot assay[J]. Clin Vaccine Immunol,2012,19(3):401-410.
8 Feng Y,Diao N,Shao L,et al. Interferon-gamma release assay performance in pulmonary and extrapulmonary tuberculosis[J]. PLoS One,2012,7(3):e32652.
9 Xu J,Li Z,Chen X,et al. More significance of TB-IGRA except for the diagnose of tuberculosis[J]. J Clin Lab Anal,2018,32:e22183. |